卵巢抑制:早期更年期和晚期影响
Chiara Molinelli1,2, Flavia Jacobs3, Guilherme Nader-Marta4
1Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy.
Current treatment options in oncology
|March 13, 2024
概括
抑制卵巢功能对于绝经前乳腺癌患者至关重要,但会引起副作用. 管理这些副作用对于改善生活质量和治疗坚持至关重要.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 大多数乳腺瘤 (90%) 是早期的,70%是荷尔蒙受体阳性.
- 内分泌疗法是早期激素受体阳性乳腺癌的主要辅助治疗方法.
- 卵巢功能抑制 (OFS) 是绝经前患者的关键,用于辅助内分泌疗法和化疗期间的卵巢保护.
研究的目的:
- 突出卵巢功能抑制在绝经前乳腺癌治疗中的重要性.
- 讨论OFS影响患者生活质量的重大副作用.
- 强调需要临床医生的知识和对OFS副作用的积极管理.
主要方法:
- 对激素受体阳性乳腺癌当前内分泌治疗指南的审查.
- 卵巢功能抑制在辅助和转移环境中的作用的分析.
- 与OFS相关的常见副作用的识别和分类.
主要成果:
- OFS是治疗荷尔蒙受体阳性乳腺癌的绝经前患者的标准组成部分.
- OFS可能导致显著的副作用,包括热,抑郁,认知问题,骨质疏松症,性功能障碍和体重增加.
- 有效管理这些副作用对于患者的福祉至关重要.
结论:
- 临床医生必须对OFS副作用有充分的了解.
- 积极的患者咨询和对OFS副作用的管理对于幸存者护理至关重要.
- 改善管理可以提高乳腺癌幸存者的治疗坚持和患者的生活质量.
更多相关视频
相关概念视频
Menopause
158
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
158
Oogenesis
63.7K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
63.7K
Hormonal Control of the Ovarian Cycle
494
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
494
Hormonal Regulation of the Menstrual Cycle
367
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
367
Disorders of the Female Reproductive System
357
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
357
Ovarian Cycle
1.2K
The menstrual cycle includes a critical component known as the ovarian cycle, which undergoes two main phases each month—the follicular phase and the luteal phase. The follicular phase is variable and averaging around 14 days. Ovulation, triggered by a surge in luteinizing hormone (LH), marks the transition between the two phases. The second phase, the luteal phase, is relatively consistent, lasting approximately 14 days, and is marked by the activity of the corpus luteum. While a cycle...
1.2K


